CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C07604 | BRD-K16533489 | I-606051 | -- | -- | -- | Details |
| C07605 | BRD-K16533918 | BRD-K16533918 | -- | -- | -- | Details |
| C07606 | BRD-K16535949 | BRD-K16535949 | -- | -- | -- | Details |
| C07607 | BRD-K16539011 | BRD-K16539011 | -- | -- | -- | Details |
| C07608 | BRD-K16541732 | BRD-K16541732 | -- | -- | -- | Details |
| C07609 | BRD-K16542329 | zaprinast | PDE5A | Phosphodiesterase inhibitor | -- | Details |
| C07610 | BRD-K16542972 | BRD-K16542972 | -- | -- | -- | Details |
| C07611 | BRD-K16551401 | PNU-22394 | HTR2A; HTR2B; HTR2C | Serotonin receptor agonist | -- | Details |
| C07612 | BRD-K16551475 | BRD-K16551475 | -- | -- | -- | Details |
| C07613 | BRD-K16552772 | BRD-K16552772 | -- | -- | -- | Details |
| C07614 | BRD-K16554464 | BRD-K16554464 | -- | -- | -- | Details |
| C07615 | BRD-K16554956 | PTB1 | PTPN1 | AMPK activator | PTB-1 | Details |
| C07616 | BRD-K16560691 | BRD-K16560691 | -- | -- | -- | Details |
| C07617 | BRD-K16561280 | BRD-K16561280 | -- | -- | -- | Details |
| C07618 | BRD-K16561564 | BRD-K16561564 | -- | -- | -- | Details |
| C07619 | BRD-K16563572 | BRD-K16563572 | -- | -- | -- | Details |
| C07620 | BRD-K16567490 | BRD-K16567490 | -- | -- | -- | Details |
| C07621 | BRD-K16570418 | BRD-K16570418 | -- | -- | -- | Details |
| C07622 | BRD-K16582605 | WY-01-034 | -- | -- | -- | Details |
| C07623 | BRD-K16588281 | BRD-K16588281 | -- | -- | -- | Details |
| C07624 | BRD-K16598630 | BRD-K16598630 | -- | -- | -- | Details |
| C07625 | BRD-K16604218 | KUC111109N | -- | -- | KUC-111109N | Details |
| C07626 | BRD-K16604360 | BRD-K16604360 | -- | -- | -- | Details |
| C07627 | BRD-K16604405 | BRD-K16604405 | -- | -- | -- | Details |
| C07628 | BRD-K16605233 | BRD-K16605233 | -- | -- | -- | Details |
| C07629 | BRD-K16606819 | trimethadione | CACNA1G | Oxazolidine antiepileptic | -- | Details |
| C07630 | BRD-K16618170 | BRD-K16618170 | S1PR3 | Lysophospholipid receptor agonist | -- | Details |
| C07631 | BRD-K16619158 | BRD-K16619158 | -- | -- | -- | Details |
| C07632 | BRD-K16621373 | BRD-K16621373 | -- | -- | -- | Details |
| C07633 | BRD-K16621460 | BRD-K16621460 | -- | -- | -- | Details |
| C07634 | BRD-K16621777 | enobosarm | AR | Androgen receptor modulator | -- | Details |
| C07635 | BRD-K16625384 | BRD-K16625384 | -- | -- | -- | Details |
| C07636 | BRD-K16626032 | BRD-K16626032 | -- | -- | -- | Details |
| C07637 | BRD-K16633334 | BRD-K16633334 | -- | -- | -- | Details |
| C07638 | BRD-K16633354 | SA-102607 | -- | -- | -- | Details |
| C07639 | BRD-K16636143 | BRD-K16636143 | -- | -- | -- | Details |
| C07640 | BRD-K16641781 | BRD-K16641781 | -- | -- | -- | Details |
| C07641 | BRD-K16643204 | BRD-K16643204 | -- | -- | -- | Details |
| C07642 | BRD-K16643911 | BRD-K16643911 | -- | -- | -- | Details |
| C07643 | BRD-K16663346 | BRD-K16663346 | -- | -- | -- | Details |
| C07644 | BRD-K16664969 | GTP-14564 | FLT3 | FLT3 inhibitor; Tyrosine kinase inhibitor | -- | Details |
| C07645 | BRD-K16667431 | BRD-K16667431 | -- | -- | -- | Details |
| C07646 | BRD-K16670438 | BRD-K16670438 | -- | -- | -- | Details |
| C07647 | BRD-K16670827 | BRD-K16670827 | -- | -- | -- | Details |
| C07648 | BRD-K16671107 | BRD-K16671107 | -- | -- | -- | Details |
| C07649 | BRD-K16673836 | BRD-K16673836 | -- | -- | -- | Details |
| C07650 | BRD-K16681480 | BRD-K16681480 | -- | -- | -- | Details |
| C07651 | BRD-K16682693 | BRD-K16682693 | -- | -- | -- | Details |
| C07652 | BRD-K16686330 | BRD-K16686330 | -- | -- | -- | Details |
| C07653 | BRD-K16689648 | BRD-K16689648 | -- | -- | -- | Details |
| C07654 | BRD-K16694974 | BRD-K16694974 | -- | -- | -- | Details |
| C07655 | BRD-K16695519 | BRD-K16695519 | -- | -- | -- | Details |
| C07656 | BRD-K16695746 | BRD-K16695746 | -- | -- | -- | Details |
| C07657 | BRD-K16698502 | BRD-K16698502 | -- | -- | -- | Details |
| C07658 | BRD-K16701932 | Gly-Gly-PALO | -- | -- | -- | Details |
| C07659 | BRD-K16704189 | BRD-K16704189 | -- | -- | -- | Details |
| C07660 | BRD-K16705018 | BRD-K16705018 | -- | -- | -- | Details |
| C07661 | BRD-K16705434 | BRD-K16705434 | -- | -- | -- | Details |
| C07662 | BRD-K16705729 | BRD-K16705729 | -- | -- | -- | Details |
| C07663 | BRD-K16714380 | BRD-K16714380 | -- | -- | -- | Details |
| C07664 | BRD-K16715205 | BRD-K16715205 | -- | -- | -- | Details |
| C07665 | BRD-K16717061 | BRD-K16717061 | -- | -- | -- | Details |
| C07666 | BRD-K16717067 | BRD-K16717067 | -- | -- | -- | Details |
| C07667 | BRD-K16724492 | BRD-K16724492 | -- | -- | -- | Details |
| C07668 | BRD-K16727544 | BRD-K16727544 | -- | -- | -- | Details |
| C07669 | BRD-K16730781 | BRD-K16730781 | -- | -- | -- | Details |
| C07670 | BRD-K16730910 | regorafenib | FGFR1; FGFR2; FLT1; FLT4; FRK; ABL1; KDR; KIT; DDR2; PDGFRA; PDGFRB; MAPK11; RAF1; RET; BRAF; TEK | KIT inhibitor; RAF inhibitor; FGFR inhibitor; PDGFR inhibitor; VEGFR inhibitor; RET tyrosine kinase inhibitor | -- | Details |
| C07671 | BRD-K16732600 | MK-0893 | GCGR | Glucagon receptor antagonist | -- | Details |
| C07672 | BRD-K16733272 | BRD-K16733272 | -- | -- | -- | Details |
| C07673 | BRD-K16736749 | SA-1455884 | -- | -- | -- | Details |
| C07674 | BRD-K16739515 | BRD-K16739515 | -- | -- | -- | Details |
| C07675 | BRD-K16741885 | BRD-K16741885 | -- | -- | -- | Details |
| C07676 | BRD-K16746805 | BRD-K16746805 | -- | -- | -- | Details |
| C07677 | BRD-K16752617 | BRD-K16752617 | -- | -- | -- | Details |
| C07678 | BRD-K16752930 | BRD-K16752930 | -- | -- | -- | Details |
| C07679 | BRD-K16754572 | BRD-K16754572 | -- | -- | -- | Details |
| C07680 | BRD-K16757695 | PRX-08066 | HTR2B | Serotonin receptor antagonist | -- | Details |
| C07681 | BRD-K16761703 | sotrastaurin | PRKCA; PRKCB; PRKCD; PRKCE; PRKCH; PRKCQ | PKC inhibitor | -- | Details |
| C07682 | BRD-K16762525 | BRD-K16762525 | -- | -- | clarithromycin | Details |
| C07683 | BRD-K16769896 | BRD-K16769896 | -- | -- | -- | Details |
| C07684 | BRD-K16769902 | BRD-K16769902 | -- | -- | -- | Details |
| C07685 | BRD-K16772343 | BRD-K16772343 | -- | -- | -- | Details |
| C07686 | BRD-K16775575 | BRD-K16775575 | -- | -- | -- | Details |
| C07687 | BRD-K16778485 | BRD-K16778485 | -- | -- | -- | Details |
| C07688 | BRD-K16780806 | BRD-K16780806 | -- | -- | -- | Details |
| C07689 | BRD-K16782389 | BRD-K16782389 | -- | -- | -- | Details |
| C07690 | BRD-K16782770 | BRD-K16782770 | -- | -- | -- | Details |
| C07691 | BRD-K16789950 | BRD-K16789950 | -- | -- | -- | Details |
| C07692 | BRD-K16791544 | BRD-K16791544 | -- | -- | -- | Details |
| C07693 | BRD-K16792691 | BRD-K16792691 | -- | -- | -- | Details |
| C07694 | BRD-K16794723 | BRD-K16794723 | -- | -- | -- | Details |
| C07695 | BRD-K16796151 | BRD-K16796151 | -- | -- | -- | Details |
| C07696 | BRD-K16798053 | ST-4029573 | -- | -- | -- | Details |
| C07697 | BRD-K16800391 | BRD-K16800391 | -- | -- | -- | Details |
| C07698 | BRD-K16802067 | BRD-K16802067 | -- | -- | -- | Details |
| C07699 | BRD-K16803204 | filgotinib | JAK1; JAK2 | JAK inhibitor | -- | Details |
| C07700 | BRD-K16810791 | LGK-974 | PORCN | Porcupine inhibitor | -- | Details |
| C07701 | BRD-K16811158 | BRD-K16811158 | -- | -- | -- | Details |
| C07702 | BRD-K16813995 | BRD-K16813995 | -- | -- | -- | Details |
| C07703 | BRD-K16826019 | BRD-K16826019 | -- | -- | -- | Details |